Related Experiment Videos

Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding

C Moser1, H K Johansen, Z Song

  • 1Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.

Insights

Mice with a Th1 immune response showed better outcomes against Pseudomonas aeruginosa lung infections than Th2 responders. This suggests Th1 immunity may be protective in cystic fibrosis (CF) patients.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonary Medicine

Background:

  • Chronic Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients is linked to poor prognosis, characterized by high antibody responses and neutrophil presence.
  • The immune response profile, specifically T-helper (Th) cell responses, may influence infection outcomes.

Purpose of the Study:

  • To investigate the role of Th1 versus Th2 immune responses in an animal model of chronic Pseudomonas aeruginosa lung infection.
  • To compare the efficacy of infection clearance and host response between Th1-prone (C3H/HeN) and Th2-prone (BALB/c) mice.

Main Methods:

  • Establishment of a murine model using C3H/HeN and BALB/c mice challenged with alginate-embedded Pseudomonas aeruginosa.
  • Assessment of mortality rates, bacterial clearance, lung histopathology (microabscesses), and cytokine profiles (interferon-gamma and IL-4) from stimulated spleen cells.

Main Results:

  • C3H/HeN (Th1) mice exhibited significantly lower mortality (p < 0.025) and more efficient bacterial clearance compared to BALB/c (Th2) mice.
  • Histopathological analysis revealed significantly better lung tissue preservation (p < 0.02) and fewer microabscesses (p < 0.005) in C3H/HeN mice.
  • Spleen cells from C3H/HeN mice produced higher levels of interferon-gamma and lower levels of IL-4 upon stimulation, consistent with a Th1-biased response.

Conclusions:

  • A Th1-dominant immune response is associated with better control and reduced pathology during chronic Pseudomonas aeruginosa lung infection in this murine model.
  • These findings suggest that promoting a Th1 immune response could be a potential therapeutic strategy for managing chronic P. aeruginosa infections in cystic fibrosis patients.

Related Concept Videos